Jaffer A. Ajani Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction Cancer 113
Article first published online: 12 JUL 2008 | DOI: 10.1002/cncr.23661
In the current study, the author focused on a review of the published reports of modifications to the original docetaxel, cisplatin, and 5-flurouracil regimen in patients with advanced gastroesophageal cancer to determine whether the modifications improve the tolerability profile.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field